Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-02-22 16:20 Tx date 2021-02-17 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
46 - Compensation for services
|
$99,999
+46,948 vol $2.13 each |
98,961 | |
Filed 2021-01-26 20:00 Tx date 2021-01-21 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
39,876 | |
Filed 2020-09-29 18:06 Tx date 2020-09-23 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$99,999
+32,232 vol $3.10 each |
52,013 | |
Filed 2020-03-25 12:32 Tx date 2020-03-24 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,876 vol |
24,876 | |
Filed 2020-03-20 16:01 Tx date 2020-03-16 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$49,997
+12,886 vol $3.88 each |
19,781 | |
Filed 2020-03-03 14:57 Tx date 2020-02-23 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-24,875 vol |
0 | |
Filed 2020-01-07 13:17 Tx date 2020-01-02 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$49,988
+6,895 vol $7.25 each |
6,895 | |
Filed 2020-01-07 13:16 Tx date 2019-06-11 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-25 14:02 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,975,125 vol |
24,875 | |
Filed 2019-11-25 14:00 Tx date 2019-09-27 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,000,000 vol |
5,000,000 | |
Filed 2019-10-21 13:28 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,985,075 vol |
||
Filed 2019-10-21 13:28 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,985,075 vol |
14,925 | |
Filed 2019-06-20 18:48 Tx date 2019-06-12 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,000,000 vol |
3,000,000 | |
Filed 2019-06-20 18:47 Tx date 2019-06-11 |
$HUGE
FSD Pharma Inc. |
Datin, James Anthony
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|